Which clinical finding best distinguishes between gestational diabetes mellitus (GDM) and pregestational type 2 diabetes in a pregnant woman presenting at 24 weeks of gestation?

Explanation

## Distinguishing GDM from Pregestational Diabetes ### Key Diagnostic Criterion **Key Point:** The timing of glucose abnormality detection is the cardinal discriminator between GDM and pregestational diabetes. **High-Yield:** GDM is defined as glucose intolerance first recognized during pregnancy (typically second or third trimester), whereas pregestational diabetes is present before conception or diagnosed in the first trimester. ### Comparison Table | Feature | GDM | Pregestational Type 2 DM | | --- | --- | --- | | **Time of diagnosis** | Second or third trimester | Before pregnancy or first trimester | | **OGTT abnormality** | First detected at 24–28 weeks | Present at booking | | **Fasting glucose at booking** | Usually normal (<126 mg/dL) | Often >126 mg/dL | | **HbA1c at booking** | Usually <6.5% | Often >6.5% | | **Glycosuria** | May occur in both | May occur in both | ### Clinical Pearl **Clinical Pearl:** A woman with normal fasting glucose and normal HbA1c at the first antenatal visit (before 13 weeks) who then develops abnormal OGTT results at 24–28 weeks has GDM, not pregestational diabetes. This reflects the metabolic changes of pregnancy (increased insulin resistance, β-cell dysfunction) that emerge in the second trimester. ### Why OGTT Timing Matters 1. **Pregestational diabetes** is present at conception; abnormalities are detectable at booking. 2. **GDM** emerges due to pregnancy-induced insulin resistance; it becomes apparent only after 20 weeks when insulin resistance peaks. 3. Screening for GDM is performed at 24–28 weeks using the 75-g OGTT [cite:ICMR-INDIAB Guidelines]. **Mnemonic:** **T-GDM** = **T**iming is key — **G**lucose abnormality in **D**iabetes **M**ellitus (GDM) appears in second/third trimester.